Company Filing History:
Years Active: 2014
Title: Agustin Bienvenido Lage Davila: Innovator in Vaccine Development
Introduction
Agustin Bienvenido Lage Davila is a prominent inventor based in Havana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of vaccine compositions for cancer treatment. His innovative approach has the potential to enhance therapeutic options for patients suffering from tumors.
Latest Patents
Lage Davila holds a patent for a method of making a homogeneous vaccine composition comprising a conjugate of Epidermic Growth Factor (EGF) and a protein known as P64k. This patent outlines a vaccine composition designed for therapeutic use in cancer patients. The chemical conjugate produced through this method surprisingly increases immunogenic activity, leading to significant increases in anti-EGF antibody titers in humans. The vaccine preparation allows for multiple effective dose presentations, enabling an increase in immunization dose per patient without raising the frequency of immunizations or the number of immunization sites.
Career Highlights
Agustin Bienvenido Lage Davila is associated with the Centro de Inmunología Molecular (CIM), where he has been instrumental in advancing research and development in immunology. His work focuses on creating innovative solutions to combat cancer through vaccine technology.
Collaborations
Lage Davila collaborates with talented professionals in his field, including Gryssell Rodriguez Martinez and Lisel Vina Rodriguez. Their combined expertise contributes to the ongoing research and development efforts at CIM.
Conclusion
Agustin Bienvenido Lage Davila is a key figure in the field of vaccine development, with a focus on innovative solutions for cancer treatment. His contributions have the potential to significantly impact patient care and improve therapeutic outcomes.